Boston Scientific Corporation vs Lithium Americas Corp — how do they compare? Boston Scientific Corporation trades at $51 (market cap $74.19B), while Lithium Americas Corp trades at $3.27 (market cap $1.18B). The key difference: Boston Scientific Corporation is far larger — about 62.9× Lithium Americas Corp's market cap. Which is the better fit depends on your goals.
| BSX | LAC | |
|---|---|---|
Market Cap | $74.19B | $1.18B |
Sector | Health | Basic Materials |
52-Week High | $108.14 | $10.05 |
52-Week Low | $42.63 | $2.71 |
Enterprise Value | $86.27B | $1.29B |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →